197 related articles for article (PubMed ID: 10027580)
41. Plasma lipoproteins and renal function during simvastatin treatment in diabetic nephropathy.
Hommel E; Andersen P; Gall MA; Nielsen F; Jensen B; Rossing P; Dyerberg J; Parving HH
Diabetologia; 1992 May; 35(5):447-51. PubMed ID: 1521727
[TBL] [Abstract][Full Text] [Related]
42. Transvascular and urinary leakage of albumin in atherosclerotic and hypertensive men.
Pedrinelli R; Penno G; Dell'Omo G; Bandinelli S; Giorgi D; Di Bello V; Nannipieri M; Navalesi R; Mariani M
Hypertension; 1998 Aug; 32(2):318-23. PubMed ID: 9719061
[TBL] [Abstract][Full Text] [Related]
43. von Willebrand factor antigen in plasma and urine in patients with type I (insulin-dependent) diabetes mellitus with and without nephropathy.
Silveira AM; Sjöberg S; Blombäck M; Ostman J
J Diabetes Complications; 1992; 6(2):89-95. PubMed ID: 1611144
[TBL] [Abstract][Full Text] [Related]
44. 24-h ambulatory blood pressure and retinopathy in normoalbuminuric IDDM patients.
Poulsen PL; Bek T; Ebbehøj E; Hansen KW; Mogensen CE
Diabetologia; 1998 Jan; 41(1):105-10. PubMed ID: 9498638
[TBL] [Abstract][Full Text] [Related]
45. Plasma Homocysteine is Associated with Retinopathy in Type 1 Diabetic Patients in the Absence of Nephropathy.
Bulum T; Blaslov K; Duvnjak L
Semin Ophthalmol; 2016; 31(3):198-202. PubMed ID: 24785685
[TBL] [Abstract][Full Text] [Related]
46. Abnormalities in plasmas concentrations of lipoproteins and fibrinogen in type 1 (insulin-dependent) diabetic patients with increased urinary albumin excretion.
Jensen T; Stender S; Deckert T
Diabetologia; 1988 Mar; 31(3):142-5. PubMed ID: 3371576
[TBL] [Abstract][Full Text] [Related]
47. Incipient nephropathy in type 1 (insulin-dependent) diabetes.
Mathiesen ER; Oxenbøll B; Johansen K; Svendsen PA; Deckert T
Diabetologia; 1984 Jun; 26(6):406-10. PubMed ID: 6468791
[TBL] [Abstract][Full Text] [Related]
48. Lisinopril reduces albuminuria during exercise in low grade microalbuminuric type 1 diabetic patients: a double blind randomized study.
Poulsen PL; Ebbehøj E; Mogensen CE
J Intern Med; 2001 May; 249(5):433-40. PubMed ID: 11350567
[TBL] [Abstract][Full Text] [Related]
49. The effect of bromhexine on albumin excretion in insulin dependent diabetes.
Marshall SM; Shearing PA; Shelley JH; Alberti KG
Diabete Metab; 1991; 17(3):332-6. PubMed ID: 1884876
[TBL] [Abstract][Full Text] [Related]
50. Angiotensin converting enzyme inhibitor therapy to decrease microalbuminuria in normotensive children with insulin-dependent diabetes mellitus.
Cook J; Daneman D; Spino M; Sochett E; Perlman K; Balfe JW
J Pediatr; 1990 Jul; 117(1 Pt 1):39-45. PubMed ID: 2196359
[TBL] [Abstract][Full Text] [Related]
51. Ambulatory blood pressure and urinary albumin excretion in diabetic (non-insulin-dependent and insulin-dependent) hypertensive patients: relationships at baseline and after treatment by the angiotensin converting enzyme inhibitor trandolapril.
Bauduceau B; Genès N; Chamontin B; Vaur L; Renault M; Etienne S; Marre M
Am J Hypertens; 1998 Sep; 11(9):1065-73. PubMed ID: 9752891
[TBL] [Abstract][Full Text] [Related]
52. Size- and charge selectivity of glomerular filtration in Type 1 (insulin-dependent) diabetic patients with and without albuminuria.
Deckert T; Kofoed-Enevoldsen A; Vidal P; Nørgaard K; Andreasen HB; Feldt-Rasmussen B
Diabetologia; 1993 Mar; 36(3):244-51. PubMed ID: 8462774
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin II type 1 receptor gene polymorphism could influence renoprotective response to losartan treatment in type 1 diabetic patients with high urinary albumin excretion rate.
Dragović T; Ajdinović B; Hrvacević R; Ilić V; Magić Z; Andelković Z; Kocev N
Vojnosanit Pregl; 2010 Apr; 67(4):273-8. PubMed ID: 20465154
[TBL] [Abstract][Full Text] [Related]
54. Losartan modifies glomerular hyperfiltration and insulin sensitivity in type 1 diabetes.
Nielsen S; Hove KY; Dollerup J; Poulsen PL; Christiansen JS; Schmitz O; Mogensen CE
Diabetes Obes Metab; 2001 Dec; 3(6):463-71. PubMed ID: 11903420
[TBL] [Abstract][Full Text] [Related]
55. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients.
Ravid M; Savin H; Jutrin I; Bental T; Katz B; Lishner M
Ann Intern Med; 1993 Apr; 118(8):577-81. PubMed ID: 8452322
[TBL] [Abstract][Full Text] [Related]
56. Iloprost decreases urinary albumin excretion rate in patients with diabetic nephropathy.
Shindo H; Tawata M; Yokomori N; Hosaka Y; Ohtaka M; Onaya T
Diabetes Res Clin Pract; 1993; 21(2-3):115-22. PubMed ID: 7505737
[TBL] [Abstract][Full Text] [Related]
57. Determinants of urinary albumin excretion within the normal range in patients with type 2 diabetes: the Randomised Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) study.
Ritz E; Viberti GC; Ruilope LM; Rabelink AJ; Izzo JL; Katayama S; Ito S; Mimran A; Menne J; Rump LC; Januszewicz A; Haller H
Diabetologia; 2010 Jan; 53(1):49-57. PubMed ID: 19876613
[TBL] [Abstract][Full Text] [Related]
58. The association between retinopathy, nephropathy, cardiovascular disease and long-term metabolic control in type 1 diabetes mellitus: a 5 year follow-up study of 442 adult patients in routine care.
Agardh CD; Agardh E; Torffvit O
Diabetes Res Clin Pract; 1997 Mar; 35(2-3):113-21. PubMed ID: 9179466
[TBL] [Abstract][Full Text] [Related]
59. Urinary connective tissue growth factor excretion in patients with type 1 diabetes and nephropathy.
Gilbert RE; Akdeniz A; Weitz S; Usinger WR; Molineaux C; Jones SE; Langham RG; Jerums G
Diabetes Care; 2003 Sep; 26(9):2632-6. PubMed ID: 12941731
[TBL] [Abstract][Full Text] [Related]
60. Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial.
Ravid M; Brosh D; Levi Z; Bar-Dayan Y; Ravid D; Rachmani R
Ann Intern Med; 1998 Jun; 128(12 Pt 1):982-8. PubMed ID: 9625684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
